New Insight towards Radiotherapy in Personalized Medicine
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Evidence Based Medicine".
Deadline for manuscript submissions: 25 September 2024 | Viewed by 51
Special Issue Editor
2. Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781, W.K. Roentgena 5 Street, 02-781 Warsaw, Poland
Interests: soft tissue sarcoma; bone tumors; bone metastases; melanoma; skin cancer; SBRT; hypofractionation
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Authors are kindly invited to submit their contributions for the upcoming Special Issue on “New Insight towards Radiotherapy in Personalized Medicine”. This issue aims to provide high-quality data on the latest advancements at the intersection of radiotherapy and personalized medicine, a rapidly evolving domain with significant implications for cancer treatment.
Submitting original research papers and comprehensive reviews, focusing on exploring new strategies and technologies aimed at personalizing radiotherapy based on individual patient characteristics, is encouraged. The areas of interest include precision radiotherapy, combined therapy, hyperthermia with radiotherapy, biomarker-driven treatment approaches, radiogenomics, and innovative clinical trial results.
Submitting your manuscript provides an opportunity to contribute to the collective knowledge of how personalized medicine transforms radiotherapy and improves patient care. Submitting your manuscript can help advance scientific understanding in this field. We encourage you to consider submitting your work today.
Dr. Mateusz Spałek
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- radiotherapy
- precision radiotherapy
- SBRT
- radiosurgery
- radioimmunotherapy
- personalized radiotherapy
- adaptive radiotherapy
- novel techniques
